UA99901C2 - Indole compounds - Google Patents
Indole compoundsInfo
- Publication number
- UA99901C2 UA99901C2 UAA200901987A UAA200901987A UA99901C2 UA 99901 C2 UA99901 C2 UA 99901C2 UA A200901987 A UAA200901987 A UA A200901987A UA A200901987 A UAA200901987 A UA A200901987A UA 99901 C2 UA99901 C2 UA 99901C2
- Authority
- UA
- Ukraine
- Prior art keywords
- indole compounds
- compounds
- indole
- derivatives
- inflammation
- Prior art date
Links
- 150000002475 indoles Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 abstract 1
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 abstract 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 abstract 1
- 125000001041 indolyl group Chemical group 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Abstract
Indole derivatives that are useful for treating pain, inflammation and other conditions are described. Certain of the compounds are benzyl derivatives and others are benzoyl derivatives. The compounds are substituted at least at the 3 position of the indole.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US83610806P | 2006-08-07 | 2006-08-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA99901C2 true UA99901C2 (en) | 2012-10-25 |
Family
ID=41221548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200901987A UA99901C2 (en) | 2006-08-07 | 2007-08-07 | Indole compounds |
Country Status (3)
| Country | Link |
|---|---|
| CN (1) | CN101563337A (en) |
| UA (1) | UA99901C2 (en) |
| ZA (1) | ZA200900843B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2787342B1 (en) * | 2013-04-05 | 2017-11-01 | PANalytical B.V. | Preparation of sample-pellets from milk and dairy products by pressing |
| CN107417679A (en) * | 2017-08-04 | 2017-12-01 | 河南农业大学 | 1,3 azoles substitute the preparation method of pyrazine compounds |
| CN110483366B (en) * | 2018-05-14 | 2022-09-16 | 中国医学科学院药物研究所 | Indole compound and preparation method, pharmaceutical composition and application thereof |
| CN111096962A (en) * | 2020-02-17 | 2020-05-05 | 中山大学附属第六医院 | Application of fatty acid oxidation inhibitor in the preparation of medicine for the treatment of colorectal cancer |
| CN111398498B (en) * | 2020-03-19 | 2023-01-03 | 中国农业科学院蜜蜂研究所 | Application of indole-3-methyl acetate in identifying apis cerana honey and apis mellifera honey |
| CN112986065B (en) * | 2021-02-08 | 2021-08-31 | 杭州同创医学检验实验室有限公司 | Whole blood quality control product for hematology analyzer and preparation method thereof |
| CN113876789B (en) * | 2021-10-28 | 2022-05-20 | 兰州大学第一医院 | Application of Licraside in preparation of medicine for treating cholestasis |
-
2007
- 2007-08-07 UA UAA200901987A patent/UA99901C2/en unknown
- 2007-08-07 CN CNA2007800370469A patent/CN101563337A/en active Pending
-
2009
- 2009-02-04 ZA ZA200900843A patent/ZA200900843B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA200900843B (en) | 2010-03-31 |
| CN101563337A (en) | 2009-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009001327A (en) | Indole compounds. | |
| WO2008157740A3 (en) | Faah inhibitors | |
| NL301145I1 (en) | ||
| IL190632A0 (en) | Biphenyl derivatives and pharmaceutical compositions containing the same | |
| PH12017500930A1 (en) | Hsp90 inhibitor combinations | |
| EP2023926A4 (en) | Pyridonecarboxamide derivatives useful in treating hyper-proliferative and angiogenesis disorders | |
| MY147247A (en) | Organic compounds and their uses | |
| CY1113314T1 (en) | (3-Aryl-piperazin-1-yl) derivatives of 6,7-dialkoxycinazoline, 6,7-dialkoxyphalazine and 6,7-dialkoxysuccinoline | |
| TW200720268A (en) | 1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent PARP inhibitors | |
| SG170813A1 (en) | New compounds | |
| TW200714590A (en) | Heterocyclic inhibitors of MEK and methods of use thereof | |
| CL2011000101A1 (en) | Compounds derived from substituted pyridazine; hedgehog and smo signaling inhibitors; pharmaceutical composition; and use for the treatment of disorders or syndromes associated with hyperproliferative diseases. | |
| SG170024A1 (en) | Imidazole-based compounds, compositions comprising them and methods of their use | |
| IL185242A0 (en) | 3,4-substituted pyrrolidine derivatives for the treatment of hypertension | |
| WO2006036994A3 (en) | Modulators of crth2, cox-2 and faah | |
| MY147649A (en) | Benzimidazole derivatives useful in treatment of vallinoid receptor trpv1 related disorders | |
| NO20085135L (en) | Selective inhibitors of ROCK protein kinase and its use | |
| UA99901C2 (en) | Indole compounds | |
| MY146506A (en) | Substituted pyridyl amide compounds as modulators of the histamine h3 receptor | |
| MX2009009190A (en) | Heterocyclic compounds, compositions comprising them and methods of their use. | |
| WO2009071689A3 (en) | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases | |
| MX2010002926A (en) | Thieno-and furo-pyrimidine modulators of the histamine h4 receptor. | |
| TW200736229A (en) | Substituted 1H-benzimidazole-4-carboxamides are potent PARP inhibitors | |
| MX2008015775A (en) | Compounds and compositions for treatment of cancer. | |
| MX2010002667A (en) | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors. |